Handelsinvest Investeringsforvaltning Sells 183 Shares of Chemed Co. (NYSE:CHE)

Handelsinvest Investeringsforvaltning lessened its holdings in Chemed Co. (NYSE:CHE) by 34.1% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 354 shares of the company’s stock after selling 183 shares during the period. Handelsinvest Investeringsforvaltning’s holdings in Chemed were worth $227,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also added to or reduced their stakes in the business. Wealth Alliance raised its stake in Chemed by 3.0% in the 4th quarter. Wealth Alliance now owns 578 shares of the company’s stock valued at $338,000 after acquiring an additional 17 shares during the period. Legacy Wealth Asset Management LLC grew its holdings in Chemed by 0.9% in the 4th quarter. Legacy Wealth Asset Management LLC now owns 2,275 shares of the company’s stock valued at $1,330,000 after buying an additional 21 shares in the last quarter. Signaturefd LLC grew its holdings in Chemed by 5.8% in the 4th quarter. Signaturefd LLC now owns 385 shares of the company’s stock valued at $225,000 after buying an additional 21 shares in the last quarter. Ballentine Partners LLC grew its holdings in Chemed by 3.4% in the 1st quarter. Ballentine Partners LLC now owns 660 shares of the company’s stock valued at $424,000 after buying an additional 22 shares in the last quarter. Finally, Waterloo Capital L.P. grew its holdings in Chemed by 1.1% in the 4th quarter. Waterloo Capital L.P. now owns 2,252 shares of the company’s stock valued at $1,317,000 after buying an additional 25 shares in the last quarter. Institutional investors own 95.85% of the company’s stock.

Analyst Upgrades and Downgrades

CHE has been the topic of a number of research reports. StockNews.com raised Chemed from a “hold” rating to a “buy” rating in a report on Saturday, May 4th. Royal Bank of Canada decreased their price objective on Chemed from $712.00 to $697.00 and set an “outperform” rating on the stock in a report on Tuesday, May 21st.

Chemed Stock Performance

CHE opened at $539.44 on Thursday. The firm has a market cap of $8.17 billion, a P/E ratio of 29.03, a price-to-earnings-growth ratio of 2.23 and a beta of 0.43. Chemed Co. has a 52-week low of $492.84 and a 52-week high of $654.62. The business’s fifty day moving average is $552.98 and its 200-day moving average is $588.21.

Chemed (NYSE:CHE) last released its earnings results on Wednesday, April 24th. The company reported $4.68 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.09 by ($0.41). The company had revenue of $589.23 million for the quarter, compared to analyst estimates of $587.18 million. Chemed had a return on equity of 30.52% and a net margin of 12.36%. On average, research analysts predict that Chemed Co. will post 21.54 earnings per share for the current fiscal year.

Chemed Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 18th. Stockholders of record on Thursday, May 30th were issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 0.30%. The ex-dividend date of this dividend was Thursday, May 30th. Chemed’s dividend payout ratio (DPR) is currently 8.61%.

Insider Transactions at Chemed

In related news, Director Patrick P. Grace sold 284 shares of the firm’s stock in a transaction dated Wednesday, June 12th. The stock was sold at an average price of $540.98, for a total value of $153,638.32. Following the sale, the director now directly owns 3,270 shares of the company’s stock, valued at $1,769,004.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In related news, CEO Kevin J. Mcnamara sold 1,500 shares of the firm’s stock in a transaction dated Thursday, June 6th. The stock was sold at an average price of $544.17, for a total value of $816,255.00. Following the sale, the chief executive officer now directly owns 107,049 shares of the company’s stock, valued at $58,252,854.33. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Patrick P. Grace sold 284 shares of the firm’s stock in a transaction dated Wednesday, June 12th. The shares were sold at an average price of $540.98, for a total value of $153,638.32. Following the completion of the sale, the director now directly owns 3,270 shares in the company, valued at $1,769,004.60. The disclosure for this sale can be found here. In the last three months, insiders have sold 5,784 shares of company stock valued at $3,240,053. 3.32% of the stock is owned by corporate insiders.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.